SCHEMBL1133065

SCHEMBL1133065

CC(=O)c1ccc(-c2cccs2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ABL1 P00519 4/20 0.53
BCR P11274 4/20 0.53
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
LMNA P02545 1/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 3/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
HDAC2 Q92769 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
LTA4H P09960 1/20 0.48
HSD17B1 P14061 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A4 P31645 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27605045 0.84 ABL1 (0.55) ABL1BCRKDM4EALDH1A1L3MBTL1
SCHEMBL4052204 0.84 FYN (0.57) MAPTKDM4EALDH1A1L3MBTL1LMNA
SCHEMBL420705 0.82 KDM4E (0.55) MAPTABL1BCRKDM4EALDH1A1
Acetic Acid SCHEMBL27477993 0.82 KDM4E (0.52) MAPTABL1BCRKDM4EALDH1A1
SCHEMBL3081682 0.81 CHEK1 (0.62) MAPTABL1BCRKDM4EALDH1A1
SCHEMBL1020361 0.81 ABL1 (0.53) ABL1BCRKDM4EALDH1A1L3MBTL1
SCHEMBL7336149 0.80 MAPT (0.66) MAPTABL1BCRKDM4EALDH1A1
SCHEMBL30887807 0.80 KDM4E (0.53) MAPTSMN1; SMN2ABL1BCRKDM4E
SCHEMBL13689286 0.80 SLC6A2 (0.54) ABL1BCRKDM4EALDH1A1L3MBTL1
SCHEMBL3193250 0.80 MAPT (0.66) MAPTABL1BCRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2023-09-28 US disclosed
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2023-09-28 US disclosed
CN-113230240-B 1,3-diphenylprop-2-en-1-one derivative and application thereof 广州医科大学 2022-12-27 CN disclosed
CN-113230240-A 1, 3-diphenylprop-2-en-1-one derivative and application thereof 广州医科大学 2021-08-10 CN disclosed
US-9845317-B2 Slow release of organoboronic acids in cross-coupling reactions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-12-19 US disclosed
US-20160376260-A1 Slow Release of Organoboronic Acids in Cross-Coupling Reactions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2016-12-29 US disclosed
EP-1306131-B1 Cross-coupling process using a catalyst comprising a cyclic nitrogen ligand SUMITOMO CHEMICAL CO (JP) 2016-12-07 EP disclosed
US-9328102-B2 Slow release of organoboronic acids in cross-coupling reactions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-05-03 US disclosed
EP-2287141-B1 METHOD FOR PRODUCING UNSATURATED ORGANIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2015-10-21 EP disclosed
US-20150246905-A1 Slow Release of Organoboronic Acids in Cross-Coupling Reactions NATIONAL SCIENCE FOUNDATION 2015-09-03 US disclosed
US-20040048858-A1 Chalcone derivatives and their use to treat diseases CRABTREE ACQUISITION CO, LLC 2004-03-11 US disclosed
US-20030162950-A1 Coupling catalyst and process using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2003-08-28 US disclosed
CN-1432140-A Solid imaging compositions for making polypropylene-like articles DSM NV (NL) 2003-07-23 CN disclosed
WO-2003053368-A2 CHALCONE DERIVATIVES AND THEIR USE TO TREAT DISEASES ATHEROGENICS, INC. (US) 2003-07-03 WO disclosed
EP-1306131-A2 Cross-Coupling catalyst comprising a cyclic nitrogen ligand and process using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-05-02 EP disclosed
US-4994623-A Process for producing thioalkyl or thioarylphenones HOECHST CELANESE CORPORATION (US) 1991-02-19 US disclosed
EP-0140540-B1 PHOTOCHROMIC COMPOUNDS AND THEIR USES IN PHOTOREACTIVE LENSES THE PLESSEY COMPANY plc (GB) 1990-05-09 EP disclosed
EP-0361790-A1 Process for producing alkylthio or arylthiophenones HOECHST CELANESE CORPORATION (US) 1990-04-04 EP disclosed
US-4685783-A Polychromic tetracyclo-spiro-adamatylidene derivatives, and polychromic lens incorporating said compounds THE PLESSEY COMPANY P.L.C. (GB) 1987-08-11 US disclosed
EP-0140540-A2 Photochromic compounds and their uses in photoreactive lenses THE PLESSEY COMPANY plc (GB) 1985-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150246905-A1 Slow Release of Organoboronic Acids in Cross-Coupling Reactions BRS3, CD79B, GRB2 MAPT 3222/4885SMN1; SMN2 537/4885ABL1 392/4885
US-20030162950-A1 Coupling catalyst and process using the same NOD1, PYM1, C9 MAPT 4796/4885SMN1; SMN2 990/4885ABL1 834/4885
US-20160376260-A1 Slow Release of Organoboronic Acids in Cross-Coupling Reactions BRS3, CD79B, GRB2 MAPT 3222/4885SMN1; SMN2 537/4885ABL1 392/4885
US-20230303543-A1 NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF LDHA, SDHA, LDHB MAPT 1699/4885SMN1; SMN2 1819/4885ABL1 4032/4885
US-20040048858-A1 Chalcone derivatives and their use to treat diseases CYP46A1, CYP11B1, HSD17B7 MAPT 1460/4885SMN1; SMN2 2245/4885ABL1 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.